Publication | Open Access
Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report
96
Citations
22
References
2021
Year
Homologous and heterologous booster vaccinations were well-tolerated and immunogenic in adults who completed a primary Covid-19 vaccine regimen at least 12 weeks earlier.
| Year | Citations | |
|---|---|---|
Page 1
Page 1